article thumbnail

KCL molecular communication system to revolutionise drug delivery

Pharma Times

The platform safely and effectively replicates the electric signalling process compounds - News - PharmaTimes

article thumbnail

Open communication helps ulcerative colitis patients through COVID-19

pharmaphorum

Gastroenterologist Dr Séverine Vermeire explains how lockdowns and communication changes over COVID-19 are taking their toll on ulcerative colitis patients and how we can best support them in the new normal. The COVID-19 pandemic might have changed everything about how we communicate, but as humans we still crave social interaction.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The Benefits of Integrated CDMO Services: Streamlining Drug Development and Manufacturing

Drug Patent Watch

billion in 2022 and is expected to grow at a compound annual growth rate of 5.3% Simplified Communication and Coordination : Integrated CDMOs can improve cross-team coordination between research, development, and manufacturing, reducing the need for external hand-offs, technology transfer, and knowledge dissemination. .”

article thumbnail

Sustainable method converting waste into pharmaceuticals developed

European Pharmaceutical Review

A team of researchers in Japan have developed a novel artificial photosynthesis method that transforms waste organic compounds into valuable pharmaceuticals and energy using sunlight and water. The paper was published in Nature Communications.

article thumbnail

Advancements in Compounding – A Commitment to Integrity and Quality

epicur

Below, Jamie shares her perspective on the advancements in compounding based on her visit to the Stokes Healthcare facility. The Complexities of Laws and Regulations around Compounding We also discussed updated pharmacy regulations regarding compounding laws. Creativity is the key more often than not. Explore our 503B Facility!

article thumbnail

Molecular 'super-glue' shows promise of cancer drug discovery platform

World Pharma News

Jude Children's Research Hospital scientists published their work on SJ3149, a compound with broad activity against many cancer types, particularly acute myeloid leukemia (AML). The findings were reported in Nature Communications. SJ3149 sticks to the cancer-related protein casein kinase 1 alpha (CK1α), leading to its destruction.

article thumbnail

Merck attempts to reduce levels of carcinogenic compounds in diabetes drugs

Pharmafile

Pharmaceutical company Merck has announced that it is attempting to reduce levels of a cancer-causing compound which has been found in its popular type 2 diabetes drugs. The compound, known as nitrosamines or NTTP, often emerges from chemical reactions that can take place throughout the manufacturing process. read more